K. Lane

发表

Regional Differences in the Use of Sentinel Lymph Node Biopsy for Melanoma: A Potential Quality Measure

S. Greenfield, D. Hsiang, J. Butler, 2008, The American surgeon.

Primary Tumor Characteristics Predict Sentinel Lymph Node Macrometastasis in Breast Cancer

L. Esserman, C. Ewing, Ying-jv Lu, 2005 .

Top-line summary SENTINEL LYMPH NODE DISSECTION IN EARLY-STAGE BREAST CANCER Standards , controversies and future considerations

L. Esserman, K. Lane, 2004 .

SENTINEL LYMPH NODE DISSEC TION IN EARLY-STAGE BREAST CANC ER Standards, controversies and future considerations

L. Esserman, K. Lane, 2004 .

LONG-TERM FOLLOW-UP OF BREAST CONSERVING THERAPY IN INFLAMMATORY BREAST CANCER PATIENTS TREATED WITH NEOADJUVANT CHEMOTHERAPY

D. Hsiang, J. Butler, J. Chen, 2015 .

Long-term Follow-up of Breast-conserving Therapy in Patients with Inflammatory Breast Cancer Treated with Neoadjuvant Chemotherapy

D. Hsiang, J. Butler, M. Su, 2014, The American surgeon.

Diagnostic Performance of MRI for Assessing Tumor Response in HER2 Negative Breast Cancer Receiving Neoadjuvant Chemotherapy Is Associated with Molecular Biomarker Profile

D. Hsiang, J. Butler, M. Su, 2012 .

Do Breast Columnar Cell Lesions with Atypia Need to be Excised?

D. Hsiang, J. Butler, N. Narula, 2007, The American surgeon.

A Randomized Prospective Study of Lumpectomy Margin Assessment with Use of MarginProbe in Patients with Nonpalpable Breast Malignancies

Thomas Frazier, Sheldon Feldman, Scott Karlan, 2014, Annals of Surgical Oncology.

Primary tumor characteristics predict sentinel lymph node macrometastasis in breast cancer.

L. Esserman, C. Ewing, Ying-jv Lu, 2006, The breast journal.

Does Immediate Tissue Expander Placement Increase Immediate Postoperative Complications in Patients with Breast Cancer?

G. Evans, G. Wirth, K. Paydar, 2015, The American surgeon.

Breast cancer: evaluation of response to neoadjuvant chemotherapy with 3.0-T MR imaging.

Hon J. Yu, S. Feig, D. Hsiang, 2011, Radiology.

Unusual Benign Breast Lesions

K. Lane, Ashley Kempf, 2007 .

Innovations in Breast Cancer Care

L. Esserman, E. Hwang, C. Ewing, 2005 .

Association of hypertension, diabetes, dyslipidemia, and metabolic syndrome with obesity: findings from the National Health and Nutrition Examination Survey, 1999 to 2004.

N. Nguyen, C. Magno, J. Lane, 2008, Journal of the American College of Surgeons.

Safety of immediate transverse rectus abdominis myocutaneous breast reconstruction for patients with locally advanced disease.

L. Esserman, R. Foster, J. Anthony, 2005, Archives of surgery.

Risk factors for premature peripheral vascular disease: results for the National Health and Nutritional Survey, 1999-2002.

E. Vittinghoff, J. Hiramoto, L. Messina, 2006, Journal of vascular surgery.

Benign Metastasizing Leiomyoma to the Lung and Spine: A Case Report and Literature Review

R. Mehta, R. Parajuli, K. Lane, 2019, Case Reports in Oncology.

Predicting nodal status using dynamic contrast-enhanced magnetic resonance imaging in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy with and without sequential trastuzumab.

D. Hsiang, J. Butler, M. Su, 2007, Archives of surgery.

Is There a Preferred Incision Location for Nipple-Sparing Mastectomy? A Systematic Review and Meta-Analysis

D. Daar, G. Wirth, William J. Rifkin, 2019, Plastic and reconstructive surgery.

The Predictive Value of Sentinel Lymph Node Biopsy in Locally Advanced Breast Cancer Patients who Have Undergone Neoadjuvant Chemotherapy

D. Hsiang, J. Butler, M. Su, 2007, The American surgeon.

Mastectomy — Then and Now *

L. Esserman, E. Hwang, C. Ewing, 2005 .

Accuracy of selective sentinel lymphadenectomy after neoadjuvant chemotherapy: effect of clinical node status at presentation.

L. Esserman, E. Hwang, H. Rugo, 2004, Journal of the American College of Surgeons.

Impact of factors affecting the residual tumor size diagnosed by MRI following neoadjuvant chemotherapy in comparison to pathology

D. Hsiang, J. Butler, M. Su, 2014, Journal of surgical oncology.

Diagnostic performance of magnetic resonance imaging for assessing tumor response in patients with HER2-negative breast cancer receiving neoadjuvant chemotherapy is associated with molecular biomarker profile.

Hon J. Yu, S. Feig, D. Hsiang, 2012, Clinical breast cancer.

Title Diagnostic Performance of MRI for Assessing Tumor Response in HER 2 Negative Breast Cancer Receiving Neoadjuvant Chemotherapy Is Associated with Molecular Biomarker

Hon J. Yu, D. Hsiang, J. Butler, 2012 .

Provider perceptions and expectations of breast cancer posttreatment care: a University of California Athena Breast Health Network project

R. Hiatt, J. Pierce, P. Ganz, 2013, Journal of Cancer Survivorship.

Nutrition impacts the prevalence of peripheral arterial disease in the United States.

S. Greenfield, D. Hoyt, C. Magno, 2008, Journal of vascular surgery.

Impact of factors affecting the residual tumor size diagnosed by MRI following neoadjuvant chemotherapy in comparison to pathology

D. Hsiang, J. Butler, M. Su, 2014, Journal of surgical oncology.